BCG vaccination in South African HIV-exposed infants--risks and benefits.
Hesseling
A C
AC
Desmond Tutu TB Centre, Stellenbosch University. annekeh@sun.ac.za
Caldwell
J
J
Cotton
M F
MF
Eley
B S
BS
Jaspan
H B
HB
Jennings
K
K
Marais
B J
BJ
Nuttall
J
J
Rabie
H
H
Roux
P
P
Schaaf
H S
HS
D000276:Adjuvants, Immunologic / Q000592:standards; D001500:BCG Vaccine / Q000592:standards; D000075202:Contraindications; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000635:transmission; D018023:HIV Seronegativity / Q000276:immunology; D006291:Health Policy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D018570:Risk Assessment; D013019:South Africa; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine